搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
搜狐
28 天
首个国内自主研发IL-4Rα抗体药物康悦达获批,填补国产特应性皮炎 ...
2024年9月12日,康诺亚宣布,公司自主研发的1类新药康悦达(司普奇拜单抗注射液)正式获得国家药品监督管理局批准上市,用于治疗成人中重度特应性皮炎。作为国内首个、全球范围第二个申报并获批上市的IL-4Rα抗体药物,康悦达(司普奇拜单抗)的上市,不 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Inflation likely cooled again
How to help Milton victims
Ethel Kennedy dies at 96
Announces retirement
Files suit against accuser
Top colleges hit with lawsuit
Meat, poultry items recalled
Ex-AR deputy sentenced
Walz on Electoral College
Rare comet in October
Benefits set to rise
Sex trafficking trial set
US warns of solar storm
‘New evidence’ emerges
Jobless claims surge
T-shirt appeal to SCOTUS
AZ Senate debate takeaways
To campaign for Harris
Idaho murder trial delayed
Nobel Prize in literature
Appeals court weighs fate
Pleads guilty to US charges
Suffers outage across US
Afghan man worked for CIA?
Tesla robotaxi launch
Internet Archive hacked
Mets advance to NLCS
GSK to settle 80K lawsuits
反馈